The Interdisciplinary Center for Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM) at the University of Munich

Flyer Patinfo English 130

Flyer of the GEPNET-Center


The University Hospital at the University of Munich focusses expertise in patient management and translational and clinical research  in oncology at the Comprehensive Cancer Center CCCLMU.

The  Interdisciplinary Center for Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM) at the University of Munich is one of the approved centers of the Comprehensive Cancer Center CCCLMU and has been certified by the European Neuroendocrine Tumor Society (ENETS) as a  Center of Excellence.

The Interdisciplinary Centre for Neuroendocrine Tumours of the Gastroenteropancreatic System at Munich University Clinic (GEPNET-KUM) is a centre striving to provide top notch optimal and integrated medical health care for patients with neuroendocrine tumors of the gastroenteropancreatic system. The centre shall not only use state of the art diagnostics and therapeutics – it will also offer the most innovative and recent diagnostics and therapy options from different disciplines. In this way, translational knowledge and clinical research shall be used for the benefit of patients.

Neuroendocrine Tumors derived from the  GastroEnter-Pankreatic System; primary tumor location can be found in the small intestine (jejunum/Ileum), the pancreas, the appendix, the colon, the stomach, the duodenum or the rectum. Frequently diagnosis is established by liver metastasis; the primary tumor is sometimes unknown (cancer of unknown primary, CUP). 

The following tumor entities belong to the neuroendocrine neoplasias / neuroendokrinen tumors:

• Neuroendocrine Tumor

• Neuroendocrine Carcinoma

• Carcinoid

• Goblet cell Carcinoid


• Functionally active neuroendocrine tumors, with clinical syndromes, e.g.:

• Carcinoid-Syndrom

• Insulinoma

• Gastrinoma (Zollinger-Ellison-Syndrome)

• VIPoma (Werner-Morrison-Syndrome)

• Glucagonoma

Familial tumor syndromes with genetic background for neuroendocrine tumors, e.g.:

• Multiple Endocrine Neoplasia Type 1 (MEN 1)

• Von-Hippel-Lindau Syndrome (VHL)